Literature DB >> 1310460

Activation of hepatitis C virus following immunosuppressive treatment.

M Yoshiba, K Sekiyama, F Sugata, H Kanamori, F Kodama, H Okamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1310460     DOI： 10.1007/bf01307747

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.

Authors:  R M Galbraith; A L Eddleston; R Williams; A J Zuckerman
Journal:  Lancet       Date:  1975-09-20       Impact factor: 79.321

2.  Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.

Authors:  J H Hoofnagle; G M Dusheiko; D F Schafer; E A Jones; K C Micetich; R C Young; J Costa
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

3.  Hepatitis B virus markers in children with acute leukemia: the effect of chemotherapy.

Authors:  A Locasciulli; M Santamaria; G Masera; E Schiavon; A Alberti; G Realdi
Journal:  J Med Virol       Date:  1985-01       Impact factor: 2.327

4.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

Authors:  A S Lok; R H Liang; E K Chiu; K L Wong; T K Chan; D Todd
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

5.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
  5 in total
  1 in total

1.  Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.

Authors:  M Yoshiba; K Sekiyama; K Inoue; R Fujita
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.